Also trades as: ACW.AX (ASX) · $vol 0M
ATGGF OTC
Actinogen Medical Limited
1W: +71.4%
1M: +71.4%
3M: +7400.0%
YTD: +50.0%
1Y: +140.0%
3Y: +150.0%
5Y: +71.4%
$0.06
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$18M
-132.1% ▼
Capital Expenditures
$9K
+75.6% ▲
5Y CAGR: +8.4%
Free Cash Flow
-$18M
-131.0% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+100.0% ▲
Net Change in Cash
$1M
-85.2% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$9M | -$11M | -$13M | $0 | -$15M |
| Depreciation & Amort. | $401K | $406K | $417K | $0 | $419K |
| Stock-Based Comp. | $1M | $2M | $0 | $0 | $0 |
| Change in Working Capital | -$2M | $132K | -$6M | $4M | -$5M |
| Other Non-Cash Items | $4M | $2M | $1M | -$11M | $2M |
| Operating Cash Flow | -$10M | -$9M | -$17M | -$8M | -$18M |
| — Investing Activities — | |||||
| Capital Expenditures | -$3K | -$37K | -$8K | -$38K | -$9K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$3K | -$37K | -$8K | -$38K | -$9K |
| — Financing Activities — | |||||
| Net Debt Issuance | -$71K | -$78K | -$92K | $3M | $1M |
| Stock Repurchased | -$831K | $0 | -$1M | -$530K | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $0 | $0 | -$61K | -$71K |
| Financing Cash Flow | $12M | $825K | $18M | $15M | $18M |
| Net Change in Cash | $3M | -$8M | $991K | $7M | $1M |
| Cash End of Period | $16M | $8M | $9M | $17M | $17M |
| Free Cash Flow | -$10M | -$9M | -$17M | -$8M | -$18M |